🇺🇸 FDA
Pipeline program

SODIUM CHLORIDE , DYNE-101

DYNE101-DM1-301

Phase 3 small_molecule active

Quick answer

SODIUM CHLORIDE , DYNE-101 for Myotonic Dystrophy Type 1 is a Phase 3 program (small_molecule) at Dyne Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Dyne Therapeutics
Indication
Myotonic Dystrophy Type 1
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials